1. Home
  2. CLS vs CTLT Comparison

CLS vs CTLT Comparison

Compare CLS & CTLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLS
  • CTLT
  • Stock Information
  • Founded
  • CLS 1994
  • CTLT 2007
  • Country
  • CLS Canada
  • CTLT United States
  • Employees
  • CLS N/A
  • CTLT N/A
  • Industry
  • CLS Electrical Products
  • CTLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLS Technology
  • CTLT Health Care
  • Exchange
  • CLS Nasdaq
  • CTLT Nasdaq
  • Market Cap
  • CLS 10.4B
  • CTLT 11.1B
  • IPO Year
  • CLS 1998
  • CTLT 2014
  • Fundamental
  • Price
  • CLS $92.08
  • CTLT $63.48
  • Analyst Decision
  • CLS Strong Buy
  • CTLT Hold
  • Analyst Count
  • CLS 9
  • CTLT 6
  • Target Price
  • CLS $75.78
  • CTLT $63.40
  • AVG Volume (30 Days)
  • CLS 2.2M
  • CTLT 3.3M
  • Earning Date
  • CLS 01-27-2025
  • CTLT 02-07-2025
  • Dividend Yield
  • CLS N/A
  • CTLT N/A
  • EPS Growth
  • CLS 88.40
  • CTLT N/A
  • EPS
  • CLS 3.16
  • CTLT N/A
  • Revenue
  • CLS $9,240,800,000.00
  • CTLT $4,422,000,000.00
  • Revenue This Year
  • CLS $21.97
  • CTLT $8.77
  • Revenue Next Year
  • CLS $8.98
  • CTLT $8.42
  • P/E Ratio
  • CLS $30.16
  • CTLT N/A
  • Revenue Growth
  • CLS 17.52
  • CTLT 4.71
  • 52 Week Low
  • CLS $26.62
  • CTLT $42.07
  • 52 Week High
  • CLS $100.51
  • CTLT $63.50
  • Technical
  • Relative Strength Index (RSI)
  • CLS 56.65
  • CTLT 74.48
  • Support Level
  • CLS $87.83
  • CTLT $63.02
  • Resistance Level
  • CLS $100.51
  • CTLT $63.25
  • Average True Range (ATR)
  • CLS 4.14
  • CTLT 0.41
  • MACD
  • CLS -0.18
  • CTLT 0.17
  • Stochastic Oscillator
  • CLS 50.24
  • CTLT 99.29

About CLS Celestica Inc.

Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.

About CTLT Catalent Inc.

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

Share on Social Networks: